AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$34.16
+1.08 (+3.26%)
Open$33.90
Previous Close$33.08
Day High$34.45
Day Low$33.50
52W High$46.00
52W Low$22.24
Volume—
Avg Volume1.23M
Market Cap2.03B
P/E Ratio—
EPS$-7.25
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-68.2% upside
Current
$34.16
$34.16
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.55M | 40.10M | 198.27M |
| Net Income | -477,880,741 | -275,753,457 | -11,344,752 |
| Profit Margin | -764.0% | -725.8% | -5.7% |
| EBITDA | -540,592,353 | -329,270,202 | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | +56.0% | +56.0% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |